Dose optimisation of PTEN inhibitor, bpV (HOpic), and SCF for the in-vitro activation of sheep primordial follicles
Dose optimisation of PTEN inhibitor, bpV (HOpic), and SCF for the in-vitro activation of sheep primordial follicles
复制标题
DOI:
10.1080/08977194.2019.1680661
复制
发表时间:
2019-10-22
期刊:
影响因子:
1.8
通讯作者:
Alikhani, Mehdi
中科院分区:
文献类型:
--
作者:
Adib, Samane;Valojerdi, Mojtaba Rezazadeh;Alikhani, Mehdi
The in-vitro development of primordial follicles is critical for improving mammalian fertility and wildlife conservation. This study aimed to optimise the effective doses of bpV (HOpic) and stem cell factor (SCF) for the in-vitro activation of sheep primordial follicles. To do this, sheep ovarian cortex was treated with bpV (1.5, 15, and 150 mu M) and SCF (50 and 100 ng/ml). Follicular count indicated that 15 mu M bpV and 100 ng/ml SCF significantly increased normal primary follicles compared to other groups (p < 0.05). Also, a significant downregulation of P53 and PTEN, as well as the increased expression of PI3K was observed. The in-vitro maturation was more pronounced when the fragmented tissues were co-treated with selected doses of bpV and SCF. In conclusion, the combination of 15 mu M bpV and 100 ng/ml SCF was the most effective treatment strategy for the activation and survival of primordial follicles in sheep ovarian fragments.